Long-Term Survival of Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib in Real-World Clinical Practice.

导出 OA

翻译打印收藏纠错

第一作者： Junji,Furuse

第一单位： Department of Gastroenterology, Kanagawa Cancer Center, Yokohama 241-8515, Japan.

作者： Junji,Furuse ^[1] ; Namiki,Izumi ^[2] ; Kenta,Motomura ^[3] ; Yoshitaka,Inaba ^[4] ; Yoshio,Katamura ^[5] ; Yasuteru,Kondo ^[6] ; Kazuhisa,Yabushita ^[7] ; Toshiyuki,Matsuoka ^[8] ; Katsuaki,Motoyoshi ^[8] ; Masatoshi,Kudo ^[9]

作者单位： Department of Gastroenterology, Kanagawa Cancer Center, Yokohama 241-8515, Japan. ^[1] Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Musashino 180-8610, Japan. ^[2] Department of Hepatology, Aso Iizuka Hospital, Iizuka 820-8505, Japan. ^[3] Department of Diagnostic and Interventional Radiology, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan. ^[4] Department of Gastroenterology, Onomichi General Hospital, Onomichi 722-8508, Japan. ^[5] Department of Hepatology, Sendai Tokushukai Hospital, Sendai 981-3116, Japan. ^[6] Department of Internal Medicine, Fukuyama City Hospital, Fukuyama 721-8511, Japan. ^[7] Eisai Co., Ltd., Bunkyo-ku 112-8088, Japan. ^[8] Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osakasayama 589-8511, Japan. ^[9]

关键词 hepatocellular carcinoma lenvatinib overall survival real-world practice

DOI 10.3390/cancers17030479

PMID 39941845

发布时间 2025-02-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交